Microscopic Colitis
Common sites:
- 50’s and 60’s peak incidence
- F>M (~2.5:1)
- Unknown etiology
- Associated with autoimmune diseases:
- Thyroiditis (19%)
- Rheumatoid arthritis (4%)
- Fibromyalgia
- Celiac (up to 30%, but often does not respond
to Gluten-free diet)
- Lymphocytic gastritis
- “lymphocytic gastroenterocolitis”
- Drugs associated:
- Ranitidine ruscus
extract (Cyclo 3 Fort)
- PPIs
- B-adrenergic receptor blockers
- Statins
- Bisphosphonates
- SSRIs
- Ipilimumab
- others
Gross features:
- Normal endoscopy almost by definition
- May show mild erythema, congestion, and
decreased vascular markings
- Rarely ulceration caused by coexisting
infection / drug reactions
- Diffuse or patchy distribution
Histologic features:
- Collagenous colitis:
- Collagen membrane below epithelium (at least 2
RBC’s thick)
- Lymphocytosis (+)
- Dense chronic inflammatory infiltrate in lamina
propria (+)
- Crowded crypts (++)
- Lymphocytic colitis:
- No collagen membrane
- Lymphocytosis (+++) (>20 lymphocytes per 100
epithelial cells)
- Count in the surface epithelium between the
crypts
- Epithelial cell injury:
- Epithelial degeneration
- Mucin depletion
- Cuboidal shape / flattening
- Cytoplasmic basophilia
/ hypereosinophilia
- Nuclear stratification
- Crypt architecture normal or near normal
- Dense chronic inflammatory infiltrate in
superficial lamina propria (++)
- Lymphocytes and plasma cells
- Eosinophils absent or few (contrast to
collagenous colitis)
- IBD features usually absent
- “paucicellular” or “minimal
change” lymphocytic colitis:
- Minimal histologic changes
- Only slight increase in intraepithelial
lymphocytes (7 to 20 per 100 ep cells)
- Minimal epithelial changes or absent
Immunophenotype:
Marker:
|
Sensitivity:
|
Specificity:
|
|
|
|
Molecular features:
Other features:
- Chronic watery, non-bloody diarrhea
- Other abdo / GI
symptoms (but typically not n/v)
- Wt. loss (up to 48%)
- Normal physical exam
- Normal routine lab tests
- Normal scope findings
- DDx:
- IBD
- Infectious colitis
- Diverticular disease
- Enteropathy-associated T-cell lymphoma (EATL)
- Autoimmune enteropathy (especially in pediatric
patients)
- Spontaneous resolution in 18%
- Salicylates (mesalazine)
and budesonide therapy can cause remission in 86% of patients
References: